IGC PHARMA, INC. Total Liabilities and Equity
IGC PHARMA, INC. (IGC) had Total Liabilities and Equity of $9.50 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-14
- 2026-06-30: Liabilities and Equity $9.50M.
- 2026-03-31: Liabilities and Equity $9.19M.
- 2025-12-31: Liabilities and Equity $9.71M.
- 2025-09-30: Liabilities and Equity $9.74M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $9.50M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $9.19M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $9.71M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $9.74M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $7.94M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $8.75M 10-KT · filed 2026-03-18 | |
| 2024-12-31 | $9.08M 10-Q · filed 2025-02-14 | |
| 2024-09-30 | $10.37M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $10.59M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $9.90M 10-K · filed 2025-06-27 | |
| 2023-12-31 | $11.26M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $16.51M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $15.67M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $17.18M 10-K · filed 2024-06-24 | |
| 2022-12-31 | $20.07M 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $21.96M 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $24.17M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $26.83M 10-K · filed 2023-07-07 | |
| 2021-12-31 | $31.29M 10-Q · filed 2022-02-10 | |
| 2021-09-30 | $33.84M 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $34.44M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $35.87M 10-K · filed 2022-06-23 | |
| 2020-12-31 | $24.16M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $26.35M 10-Q · filed 2020-11-20 | |
| 2020-06-30 | $28.30M 10-Q · filed 2020-08-19 | |
| 2020-03-31 | $28.98M 10-K · filed 2021-06-14 | |
| 2019-12-31 | $31.10M 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $32.89M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $33.51M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $34.47M 10-K · filed 2020-07-13 | |
| 2018-12-31 | $37.16M 10-Q · filed 2019-02-12 | |
| 2018-09-30 | $16.55M 10-Q · filed 2018-10-16 | |
| 2018-06-30 | $11.52M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $10.85M 10-K · filed 2019-06-14 | $10.85M 10-K · filed 2018-06-21 |
| 2017-12-31 | $11.34M 10-Q · filed 2018-02-20 | |
| 2017-09-30 | $9.99M 10-Q · filed 2017-11-17 | |
| 2017-06-30 | $9.44M 10-Q · filed 2017-08-18 | |
| 2017-03-31 | $11.28M 10-K · filed 2018-06-21 | |
| 2016-12-31 | $11.17M 10-Q · filed 2017-02-21 | |
| 2016-09-30 | $18.86M 10-Q · filed 2016-11-21 | |
| 2016-06-30 | $18.50M 10-Q · filed 2016-08-16 | |
| 2016-03-31 | $18.86M 10-K · filed 2017-07-14 | |
| 2015-12-31 | $18.40M 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $18.82M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $20.58M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $20.33M 10-K · filed 2016-07-14 | |
| 2014-12-31 | $21.26M 10-Q · filed 2015-02-12 | |
| 2014-09-30 | $21.19M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $21.61M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $17.73M 10-K · filed 2015-07-14 | |
| 2013-12-31 | $18.19M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $18.54M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $18.58M 10-Q · filed 2013-08-16 | |
| 2013-03-31 | $19.25M 10-K · filed 2014-07-15 | |
| 2012-12-31 | $21.44M 10-Q · filed 2013-02-13 | |
| 2012-09-30 | $24.22M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $24.83M 10-Q/A · filed 2012-08-21 | |
| 2012-03-31 | $25.26M 10-K · filed 2014-07-15 | |
| 2011-12-31 | $35.10M 10-Q · filed 2012-02-16 | |
| 2011-09-30 | $16.09M 10-Q · filed 2011-11-18 | |
| 2011-06-30 | $17.49M 10-Q · filed 2011-08-18 | |
| 2011-03-31 | $18.16M 10-K · filed 2012-07-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |